Indeed, this theory extends beyond treatment strategies limited to amyloid or tau accumulation, highlighting that neuroinflammation is recognized as a critical contributing factor in AD pathology; thus, various therapeutic approaches that target this aspect are necessary. Here, MAPT is linked to Alzheimer disease.